Femtobiomed Inc. (XKON:327610)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,400.00
-185.00 (-4.03%)
At close: Aug 1, 2025, 3:30 PM KST

Femtobiomed Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2018FY 2017
Period Ending
Dec '18 Dec '17
Net Income
-1,210-1,070
Depreciation & Amortization
124.75141.76
Loss (Gain) From Sale of Assets
--1.63
Provision & Write-off of Bad Debts
1.82-
Other Operating Activities
14.0218.74
Change in Accounts Receivable
47.56-14.04
Change in Inventory
-83.0518.89
Change in Accounts Payable
--0.92
Change in Other Net Operating Assets
6.38-16.74
Operating Cash Flow
-1,099-923.94
Capital Expenditures
-134.72-72.21
Sale of Property, Plant & Equipment
-31.74
Sale (Purchase) of Intangibles
-91.01-10.23
Other Investing Activities
-4.91-98.35
Investing Cash Flow
-230.64-140.55
Long-Term Debt Repaid
-61.05-66.6
Net Debt Issued (Repaid)
-61.05-66.6
Financing Cash Flow
-61.05-66.6
Net Cash Flow
-1,390-1,131
Free Cash Flow
-1,233-996.14
Free Cash Flow Margin
-316.28%-251.83%
Free Cash Flow Per Share
-892.82-721.51
Levered Free Cash Flow
-890.34-
Unlevered Free Cash Flow
-889.89-
Change in Net Working Capital
38.82-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.